Abbott Loses Bid For Judgment In $200M Stent Case
A judge has shot down Abbott Laboratories' bid for summary judgment on Medtronic Inc.'s claims for lost profits, in a suit alleging infringement of stent patents and seeking more than $200...To view the full article, register now.
Already a subscriber? Click here to view full article